Milu Labs

Milu Labs specializes in developing and commercializing disruptive diagnostic technologies, focusing on exosomes and multiomics to provide predictive health insights. The company serves healthcare providers and patients, primarily in Asia but with a global reach. Milu Labs operates in the healthcare diagnostics market, utilizing advanced artificial intelligence to analyze data from proteomics, transcriptomics, epigenomics, and microbiomics. This integrated approach results in a single clinical test that empowers healthcare providers with actionable insights. The business model revolves around offering these advanced diagnostic tests to healthcare institutions, generating revenue through test sales and related services. The company aims to improve patient outcomes, particularly in areas such as preterm birth, by providing early and accurate diagnostic information.

Keywords: exosomes, multiomics, predictive health, diagnostics, AI analysis, healthcare, proteomics, transcriptomics, epigenomics, microbiomics.